- Home
- DFIN vs IDYA Comparison
DFIN vs IDYA Comparison
Compare DFIN & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFIN
- IDYA
- Stock Information
- Founded
- DFIN 1983
- IDYA 2015
- Country
- DFIN United States
- IDYA United States
- Employees
- DFIN N/A
- IDYA N/A
- Industry
- DFIN Other Consumer Services
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- DFIN Consumer Discretionary
- IDYA Health Care
- Exchange
- DFIN Nasdaq
- IDYA Nasdaq
- Market Cap
- DFIN 1.9B
- IDYA 2.0B
- IPO Year
- DFIN N/A
- IDYA 2019
- Fundamental
- Price
- DFIN $48.48
- IDYA $21.85
- Analyst Decision
- DFIN Strong Buy
- IDYA Strong Buy
- Analyst Count
- DFIN 3
- IDYA 13
- Target Price
- DFIN $71.33
- IDYA $53.67
- AVG Volume (30 Days)
- DFIN 256.6K
- IDYA 943.3K
- Earning Date
- DFIN 02-18-2025
- IDYA 02-13-2025
- Dividend Yield
- DFIN N/A
- IDYA N/A
- EPS Growth
- DFIN 13.75
- IDYA N/A
- EPS
- DFIN 3.06
- IDYA N/A
- Revenue
- DFIN $781,900,000.00
- IDYA $7,000,000.00
- Revenue This Year
- DFIN $8.00
- IDYA $111.81
- Revenue Next Year
- DFIN $4.41
- IDYA $240.55
- P/E Ratio
- DFIN $15.92
- IDYA N/A
- Revenue Growth
- DFIN N/A
- IDYA N/A
- 52 Week Low
- DFIN $47.94
- IDYA $19.96
- 52 Week High
- DFIN $71.01
- IDYA $47.72
- Technical
- Relative Strength Index (RSI)
- DFIN 23.29
- IDYA 43.52
- Support Level
- DFIN $47.94
- IDYA $19.96
- Resistance Level
- DFIN $67.18
- IDYA $21.65
- Average True Range (ATR)
- DFIN 2.74
- IDYA 1.09
- MACD
- DFIN -2.41
- IDYA -0.07
- Stochastic Oscillator
- DFIN 2.47
- IDYA 33.57
About DFIN Donnelley Financial Solutions Inc.
Donnelley Financial Solutions Inc is a global risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( US), Europe, Asia, Canada, and others, of which the US accounts for the vast majority of its total revenue.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.